Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis. [electronic resource]
Producer: 20200305Description: 96-102 p. digitalISSN:- 1872-8332
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Crizotinib -- therapeutic use
- Exons -- genetics
- Female
- High-Throughput Nucleotide Sequencing
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Mutation -- genetics
- Protein Kinase Inhibitors -- therapeutic use
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Retrospective Studies
- Survival Analysis
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.